Eugenia N. Uche-Anya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eugenia N. Uche-Anya has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Tyler M. Berzin
Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
2 shared publications Adjoa Anyane-Yeboa
Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
1 shared publication- Chris Labaki
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
1 shared publication - Folasade P. May
Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California; UCLA Kaiser Permanente Center for Health Equity, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California
1 shared publication Marzyeh Ghassemi
Institute for Medical and Evaluative Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
1 shared publication
Latest Publications
- 23 September 2024
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 53 (4) , 773-786
Artificial Intelligence in Gastrointestinal Endoscopy
- 23 September 2024
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 53 (4) , 773-786
Artificial Intelligence in Gastrointestinal Endoscopy
- Top Cited Papers
Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity
Artificial intelligence (AI) and machine learning (ML) systems are increasingly used in medicine to improve clinical decision-making and healthcare delivery. In gastroenterology and hepatology, studies have explored a myriad of opportunities for AI/ML applications which are already making the transition to bedside. Despite these advances, there is a risk that biases and health inequities can be introduced or exacerbated by these technologies. If unrecognised, these technologies could generate or worsen systematic racial, ethnic and sex disparities when deployed on a large scale. There are several mechanisms through which AI/ML could contribute to health inequities in gastroenterology and hepatology, including diagnosis of oesophageal cancer, management of inflammatory bowel disease (IBD), liver transplantation, colorectal cancer screening and many others. This review adapts a framework for ethical AI/ML development and application to gastroenterology and hepatology such that clinical practice is advanced while minimising bias and optimising health equity.
Top Cited PapersArtificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity
Artificial intelligence (AI) and machine learning (ML) systems are increasingly used in medicine to improve clinical decision-making and healthcare delivery. In gastroenterology and hepatology, studies have explored a myriad of opportunities for AI/ML applications which are already making the transition to bedside. Despite these advances, there is a risk that biases and health inequities can be introduced or exacerbated by these technologies. If unrecognised, these technologies could generate or worsen systematic racial, ethnic and sex disparities when deployed on a large scale. There are several mechanisms through which AI/ML could contribute to health inequities in gastroenterology and hepatology, including diagnosis of oesophageal cancer, management of inflammatory bowel disease (IBD), liver transplantation, colorectal cancer screening and many others. This review adapts a framework for ethical AI/ML development and application to gastroenterology and hepatology such that clinical practice is advanced while minimising bias and optimising health equity.